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ORIGINAL RESEARCH
Diffusion-Weighted MRI and Intravoxel
Incoherent Motion Model for Diagnosis of
Pediatric Solid Abdominal Tumors
Emma M. Meeus, MS,1,2,3 Niloufar Zarinabad, PhD,2,3 Karen A. Manias, MS, MD,2,3
Jan Novak, PhD,2,3 Heather E.L. Rose, PhD,2,3 Hamid Dehghani, PhD,1,4
Katharine Foster, MD,5 Bruce Morland, MD,3 and Andrew C. Peet, PhD, MD2,3*
Background: Pediatric retroperitoneal tumors in the renal bed are often large and heterogeneous, and their diagnosis
based on conventional imaging alone is not possible. More advanced imaging methods, such as diffusion-weighted
(DW) MRI and the use of intravoxel incoherent motion (IVIM), have the potential to provide additional biomarkers that
could facilitate their noninvasive diagnosis.
Purpose: To assess the use of an IVIM model for diagnosis of childhood malignant abdominal tumors and discrimination
of benign from malignant lesions.
Study Type: Retrospective.
Population: Forty-two pediatric patients with abdominal lesions (n532 malignant, n510 benign), verified by histopathology.
Field Strength/Sequence: 1.5T MRI system and a DW-MRI sequence with six b-values (0, 50, 100, 150, 600, 1000 s/mm2).
Assessment: Parameter maps of apparent diffusion coefficient (ADC), and IVIM maps of slow diffusion coefficient (D),
fast diffusion coefficient (D*), and perfusion fraction (f) were computed using a segmented fitting model. Histograms
were constructed for whole-tumor regions of each parameter.
Statistical Tests: Comparison of histogram parameters of and their diagnostic performance was determined using Krus-
kal–Wallis, Mann–Whitney U, and receiver-operating characteristic (ROC) analysis.
Results: IVIM parameters D* and f were significantly higher in neuroblastoma compared to Wilms’ tumors (P < 0.05).
The ROC analysis showed that the best diagnostic performance was achieved with D* 90th percentile (area under the
curve [AUC]50.935; P50.002; cutoff value5 32,376 3 1026 mm2/s) and f mean values (AUC5 1.00; P < 0.001; cutoff
value514.7) in discriminating between neuroblastoma (n5 11) and Wilms’ tumors (n5 8). Discrimination between tumor
types was not possible with IVIM D or ADC parameters. Malignant tumors revealed significantly lower ADC, D, and
higher D* values than in benign lesions (all P < 0.05).
Data Conclusion: IVIM perfusion parameters could distinguish between malignant childhood tumor types, providing
potential imaging biomarkers for their diagnosis.
Level of Evidence: 4
Technical Efficacy: Stage 2
J. MAGN. RESON. IMAGING 2017;00:000–000.
Malignant abdominal tumors in children are often diag-nosed using a combination of conventional imaging
and histology.1,2 Histological diagnosis requires an invasive
biopsy, with risk of morbidity and sampling error in large
heterogeneous lesions such as seen in the abdomen.3,4 A
conclusive diagnosis based on conventional imaging alone
can be difficult, with similar morphological appearances of
some childhood tumors.5
Magnetic resonance imaging (MRI) is increasingly
used in the diagnosis, staging, and management of pediatric
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solid tumors due to its relatively high resolution and lack of
nonionizing radiation.6 Diffusion-weighted MRI (DW-
MRI) has shown promising results with the use of apparent
diffusion coefficient (ADC) maps. Previous studies have
demonstrated that ADC can discriminate benign from
malignant solid tumors,7,8 which is likely due to the pro-
posed inverse relationship between ADC and cellularity.9,10
ADC has been determined to be lower in pediatric malig-
nant abdominal tumors in comparison to benign lesions,
relating to the more restricted diffusion and hence higher
cellularity.7 Noninvasive discrimination between individual
tumor types has not been possible in previous pediatric
studies, but would be of considerable clinical value.
The ADC approach for heterogeneous tissues such as
those found in abdominal tumors can be relatively simplistic
and does not maximize the information that can be poten-
tially extracted from the DWI.11 The intravoxel incoherent
motion (IVIM) model with multi b-value DW-MRI can
account for the pure diffusion characteristic (D), and sepa-
rate the pseudodiffusion (D*) effect caused by microcircula-
tion or blood perfusion, and determine the perfusion
fraction (f ) corresponding to the fraction of signal arising
from the vascular component.12,13 Both diffusion character-
istics influence the measured diffusion-weighted signal and
therefore limit the reliability of the ADC measurement. Pre-
vious studies have shown IVIM parameters to be helpful in
discriminating common adult malignant pancreatic tumors
as well as benign from malignant lesions.14,15 Significantly
better discrimination of low- and high-grade hepatocellular
carcinoma (HCC) has been demonstrated with IVIM-D in
comparison to ADC.16
The heterogeneous nature of abdominal tumors can be
difficult to characterize based on imaging measures such as
the mean ADC value alone.17 Histograms allow the inspec-
tion of the distribution of values corresponding to a region-
of-interest (ROI), and describe the statistical information
contained within the imaged region. However, the placing
of a single ROI on a representative tumor image can lead to
sampling bias and not provide accurate representation of the
tumor heterogeneity.18,19 Alternatively, a whole-tumor ROI
approach has been shown to largely reduce the sampling
bias and to produce excellent interobserver agreement com-
pared to single-slice ROI analysis.20 Such an approach was
also used in a study of Wilms’ tumors, which was able to
identify distinct cellular regions based on ADC histograms,
and to determine the predominant histological cell types.21
Further value of histogram analysis was shown in a study
with adult patients with glioblastoma, where the IVIM
parameter histograms were able to differentiate between
recurrent tumor and treatment effects.22
Therefore, the aim of this study was to retrospectively
evaluate the feasibility and diagnostic potential of using
IVIM and ADC histogram analysis for discriminating
between individual malignant and between benign and
malignant pediatric tumor types.
Materials and Methods
Study Population
The protocol for this retrospective study was approved by the East
Midlands–Derby Research Ethics Committee (REC 04/MRE04/
41), operating under the rules of Declaration of Helsinki 1975
(and as revised in 1983). Informed parental consent was obtained
from all subjects after the image acquisition. A computerized search
of medical records identified 55 patients who underwent abdomi-
nal MRI including DWI between June 2012 and September 2016.
All cases were reviewed by the tumor study board for suspected
solid malignancy. The following exclusion criteria were applied to
the cohort: having received treatment prior to imaging (chemother-
apy or surgery), nonsolid pathology (n5 1), incomplete or
improper MRI scans (n5 10), or small lesions where single-slice
largest area <3 cm2 or total volume <6 cm3 (n5 2). The final
population included 42 patients, comprised of 10 benign and 32
malignant cases (Fig. 1).
The cohort comprised 16 female patients (age range, 0–14
years; mean age6 standard deviation [SD], 3.66 4.2) and 26 male
patients (age range, 0–10 years; mean age6 SD, 3.36 3.0). The
age range for the whole group was 0–14 years, with a mean age6
SD 3.76 2.8 years. The malignant cases included those with clear
cell sarcoma (n5 1), Ewing’s sarcoma (n5 1), germ cell tumor
(n5 1), hepatoblastoma (n5 4), nephroblastomatosis (n5 1), neu-
roblastoma (n5 11), ovarian immature teratoma (n5 1), rhabdoid
(n5 2), rhabdomyosarcoma (n5 2), and Wilms’ tumor (n5 8).
The benign lesions consisted of indolent abdominal mass (n5 1),
ganglioneuroma (n5 3), hematocolpos (n5 1), lipoma (n5 1),
hemangioma (n5 1), mesoblastic nephroma (n5 1), osteomyelitis
(n5 1), and vascular malformation (n5 1). The mean size of the
malignant tumors was 32.1 cm (range 8.56 53.1 cm) and benign
lesions 16.8 cm (range 7.26 47.7 cm). The cohort demographics
are summarized in Table 1.
FIGURE 1: Flow diagram for patient selection based on the rec-
ommended STARD standards for reporting diagnostic accuracy.
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MRI
MRI was performed with a Siemens Avanto 1.5T (Siemens Healthcare,
Erlangen, Germany) scanner and a 4-channel body receive coil at Bir-
mingham Children’s Hospital. The imaging protocol included fat-
suppressed axial and coronal pre- and postgadolinium T1-weighted
turbo spin-echo (repetition time / echo time [TR/TE] 760 to 817/7.7
msec), axial T2-weighted turbo spin-echo (TR/TE 3000 to 5640/67 to
87 msec) and DWI acquisition. The DWI protocol used a spin-echo pla-
nar imaging (EPI) sequence with six b-values (0, 50, 100, 150, 600,
1000 s/mm2), EPI factor5 174, three averages (NSA5 3), TR/TE
3200 to 9900/92 msec, parallel imaging (GRAPPA) with an acceleration
factor of two, and 75% partial Fourier encoding. The diffusion-
weighting was applied in three orthogonal directions, of which an aver-
age image was derived in the axial acquisition plane. Depending on
patient size, the field-of-view (FOV) was 221 to 3503 172 to 317mm,
matrix size 122 to 1923 128 to 192, slice thickness 5mm with no gap
between slices and voxel size of 1 to 2.34mm23 5mm. The DWI pro-
tocol acquisition time ranged from 4min 52 sec to 7min 35 sec.
IVIM Modeling of the DW Data and Computation
of ADC
Postprocessing of the DWMR data was performed using an in-house
imaging analysis tool developed in MeVisLab platform (v. 2.7.1,
MeVis Medical Solutions, Bremen, Germany). The analysis algo-
rithm for IVIM was developed in Python (v. 2.7). The relationship
between the diffusion signal intensities and the b-values can be
described by a biexponential relationship introduced by Le Bihan12:
Sb=S05f  expð2bDÞ1ð12f Þ  expð2bDÞ (1)
where S0 and Sb are the signal intensities at b5 0 and b5 50,
100, 150, 600, or 1000 s/mm2, respectively. Using this relation-
ship, a nonlinear least-squares fit was applied to the data on a
voxel-by-voxel basis. A stepwise fitting was used to increase the sta-
bility of the biexponential fitting and the reliability of the IVIM
parameters as reported by previous studies.23–26 At high b-values
>100 s/mm2 the perfusion effects are assumed negligible as D*
D, and linear regression can be performed to compute the D
parameter from the gradient of the fit.27 The same fit can be used
to deduce the f parameter from extrapolating the fit to the y-axis
and taking the difference to the b0 signal. The biexponential fitting
was then performed using the Levenberg–Marquardt algorithm
with the predefined values of D and f to find the D* parameter.
The computation of ADC values was performed using a
monoexponential linear fit of the b-values 0 and 1000 s/mm2:
Sb
S0
5expð2b  ADCÞ (2)
The ADC and IVIM parameter maps were analyzed using in-built
histogram and ROI drawing modules. For each case, mean,
median, 5th, 25th, 75th, and 90th percentiles, skewness, kurtosis,
and entropy were calculated from the normalized histograms based
on values extracted from the ROI. The histograms were normalized
to the maximum value due to differences in ROI sizes, and to
compute average histograms for individual tumor types.
Whole tumor areas were included in the ROIs, including cystic
and necrotic areas. The ROIs were drawn manually on DW b5 0
images by an author with clinical experience (K.M.), after which they
were refined by a consultant radiologist (K.F., 10 years experience in
abdominal MRI). Any changes to the ROIs were made in consensus
of the two authors (K.M. and K.F.). Conventional MR images (T1
and T2) were used to aid delineation of tumors at each consecutive
slice, excluding peritumoral edema. On each slice, sections of tumor
that were >50% of the more central adjacent slice and 3 cm were
included to minimize any partial volume effects.
Statistical Analysis
All statistical analyses were performed using SPSS Statistics (v. 23,
Chicago, IL) software. A nonparametric Kruskal–Wallis test was
used for the comparison of IVIM and ADC histogram parameters
from the malignant tumors and Dunn’s test was performed to
TABLE 1. Patient Cohort Demographics
Lesion Cases Mean age, range (yrs) Sex (F/M)
Benign 10 4 (0-10) 3/7
Clear cell sarcoma 1 3.5 0/1
Ewing’s sarcoma 1 9.3 0/1
Germ cell 1 2.4 0/1
Hepatoblastoma 4 0.9 (0-2) 2/2
Nephroblastomatosis 1 0.1 0/1
Neuroblastoma 11 1.9 (0-6) 5/6
Ovarian immature teratoma 1 11.8 1/0
Rhabdoid 2 0.9 (0-1) 1/1
Rhabdomyosarcoma 2 5.8 (5-7) 0/2
Wilms’ tumor 8 6.1 (1-14) 4/4
Total 42 3.7 (0-14) 16/26
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determine which tumors gave rise to the difference. Mann–Whit-
ney U-test was used to establish differences between the malignant
and benign lesions. Bonferroni correction was used.
Receiver operating characteristic (ROC) curves were used to
determine how well the diffusion parameters discriminated individ-
ual tumor types, and benign from malignant lesions. The cutoff value
that demonstrated the greatest Youden index on the estimated curves
was used to determine the sensitivity and specificity. The area under
the ROC curve (AUC) was determined to assess the diagnostic per-
formance of the IVIM and ADC histogram parameters.
Voxelwise correlations between perfusion fraction and diffu-
sion parameters were assessed for whole tumor ROIs and tumor
regions where f was between 25–40%, with Pearson correlation
coefficient, r. This was performed for cases of neuroblastoma
(n5 5) and Wilms’ tumors (n5 4).
All tests performed were two-sided. Numerical values are
reported as median6 SD. P < 0.05 was considered to indicate a
significant difference.
Results
Discrimination Between Tumor Types
Distributions of median ADC and IVIM parameter values
of malignant and benign lesions are presented in Fig. 2 for
our whole patient cohort.
Comparison between the individual malignant tumor
types and their ADC, D, D*, and f histogram parameters
are presented in Table 2 with the histogram parameter val-
ues summarized in Table 3. The Kruskal–Wallis test revealed
significant differences in the histogram parameters of D* (P
0.007–0.021) and f (P < 0.001–0.008) between the malig-
nant tumors. For both D* and f these included histogram
parameters mean, median, and 75th/90th percentiles. Addi-
tionally, D* skewness and f 25th percentile, kurtosis, and
entropy showed significant differences. No differences were
observed for ADC and D histogram parameters. The Dunn’s
test revealed that the D* values of neuroblastoma were sig-
nificantly higher in comparison to Wilms’ tumor (P 0.005–
0.012) and skewness was significantly higher for Wilms’
(P5 0.017) compared to neuroblastoma. Similarly, the f val-
ues in neuroblastoma were significantly higher in compari-
son to Wilms’ tumors (P < 0.001–0.002) and higher
kurtosis (P5 0.006) and entropy (P < 0.001) were seen for
neuroblastoma.
Normalized f histograms averaged for the malignant
tumor types are shown in Fig. 3. The Wilms’ and neuro-
blastoma histogram shapes demonstrated the differences
seen in kurtosis and entropy between the tumor types.
FIGURE 2: Boxplot distributions of median ADC and IVIM parameters for different tumor types. Plots shown for (a) ADC, (b) D, (c)
D*, and (d) f parameter. Top and bottom of boxes represent 25% and 75% percentiles of data values, respectively, and the hori-
zontal lines in boxes represent the median. The whiskers extend to the most extreme data points not considered outliers and out-
liers are indicated by red circles.
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Kurtosis, which indicates the sharpness of a frequency-
distributed curve, was found to be higher and closer to nor-
mally distributed data in neuroblastoma in comparison to
Wilms’. The higher entropy of neuroblastoma was observed
as a more irregularly distributed histogram, with greater
deviation seen between the cohort cases.
ROC analysis was performed for D* and f histogram
parameters to study the diagnostic performance of discrimi-
nating neuroblastoma from Wilms’ tumor, with the results
summarized in Table 4. The D* histogram parameters
mean, median, 75th/90th percentiles, and skewness could
discriminate the two tumor types with AUC values >0.900
(range, 0.909–0.935; P5 0.002–0.004). The f histogram
parameters mean, median, 5th/25th/75th/90th, kurtosis, and
entropy could discriminate Wilms’ from neuroblastoma,
with mean, median, 25th/75th/90th, and entropy demon-
strating AUC values >0.900 (range, 0.938–1.00; P <
0.001–0.029).
Representative parametric maps of Wilms’ tumor and
neuroblastoma are shown in Figs. 4 and 5, respectively. The
ADC and D maps were similar in appearance, although D
was generally lower in comparison to ADC and some
regions suggested drops in DW signal when b-value >0,
seen as a lower intensity on D map in comparison to ADC.
For both Wilms’ and neuroblastoma, the D* maps appeared
the most heterogeneous, indicating greater variability of val-
ues, which accounted for the high histogram entropy. In ref-
erence to the healthy kidneys seen on the f maps, a lower
vascular character was suggested for the Wilms’ case (Fig.
4), while more variability was observed for neuroblastoma
(Fig. 5).
No correlation between IVIM and ADC parameters
was found in the image regions where f was high (25–40%),
suggesting that the higher f and D* values resulted from
pathological origins rather than image artifacts. However,
the overall voxelwise correlations in neuroblastoma and
Wilms’ cases demonstrated a negative correlation for D and
f, while ADC and f showed positive correlation.
Discrimination Between Benign and Malignant
Lesions
The discrimination between benign and malignant lesions
was possible with ADC, D, and D* parameters (Supplemen-
tary Table S1). The ADC, D, D*, and f for benign lesions
were as follows: ADC5 15976 484 (31026 mm2/s),
D5 15526 622 (31026 mm2/s), D*5 11,6106 3385
(31026 mm2/s), and f5 166 6.7%. Both ADC and D
were found to be significantly lower and D* significantly
higher in malignant tumors. Most ADC histogram parame-
ters demonstrated a significant difference with lower mean
(P5 0.007), median (P5 0.001), 5th percentile
(P5 0.005), 25th percentile (P5 0.007), 75th percentile
(P5 0.007) and higher kurtosis (P < 0.001), skewness (P
< 0.001), and entropy (P5 0.036) for malignant tumors.
The D parameter was only found to discriminate malignant
tumors with lower median (P5 0.049), 25th percentile
(P5 0.045), and higher skewness (P5 0.018). While the f
parameter was not found to not show difference between
the benign and malignant lesions, the D* parameter demon-
strated higher median (P5 0.039) and entropy (P5 0.002)
in malignant tumors.
ROC analysis was performed for the diffusion parame-
ters that demonstrated a significant difference between
benign and malignant lesions (summarized results can be
found in Supplementary Table S2). The ROC curves corre-
sponding to median histogram values together with the
highest resulting AUC values for ADC, D, and D* are pre-
sented in Fig. 6. The analysis showed that the median values
of ADC 1219 3 1026 mm2/s, D 1242 3 1026 mm2/s,
TABLE 2. Comparison of Malignant Tumor Types
Parameter
Kruskal-Wallis test (P value) Dunn’s test (P value)
ADC D D* f ADC D D* f
Mean 0.470 0.277 0.013 < 0.001 — — NB-W5 0.010 NB-W< 0.001
Median 0.273 0.198 0.013 < 0.001 — — NB-W5 0.010 NB-W< 0.001
5th percentile 0.201 0.088 0.944 0.110 — — — —
25th percentile 0.151 0.142 0.413 0.003 — — — NB-W5 0.002
75th percentile 0.244 0.340 0.015 < 0.001 — — NB-W5 0.012 NB-W< 0.001
90th percentile 0.392 0.405 0.007 0.001 — — NB-W5 0.005 NB-W< 0.001
Kurtosis 0.395 0.445 0.651 0.008 — — — NB-W5 0.006
Skewness 0.183 0.344 0.021 0.651 — — NB-W5 0.017 —
Entropy 0.462 0.466 0.974 0.001 — — — NB-W< 0.001
HB: Hepatoblastoma; NB: Neuroblastoma; W: Wilms’ tumor; with ADC, D, D*, and f histogram parameters.
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and D* 11,104 3 1026 mm2/s were the most accurate cut-
off levels, with sensitivity and specificity of 80.0% and
81.3% for ADC, 66.7% and 87.9% for D, and 55.6% and
93.8% for D*. The ADC was found to have better diagnos-
tic performance than D or D* for discriminating benign
from malignant tumors, with AUC values 0.825 (range,
0.659–0.991, P5 0.002) for ADC, 0.717 (range, 0.458–
0.977, P5 0.048) for D and 0.736 (range, 0.528–0.945,
P5 0.032) for D*.
The best diagnostic performance was achieved with
skewness for ADC and D and entropy for D* with AUC
values 0.919 (range, 0.823–1.00, P < 0.001), 0.758 (range,
0.495–1.00, P5 0.019), and 0.840 (range, 0.711–0.969,
P5 0.002), respectively. The optimal cutoff values were
ADC skewness: 3.30 3 1022 (sensitivity 70.0%, specificity
100%), D skewness: 3.56 3 1022 (sensitivity 77.8%, specif-
icity 87.9%), and D* entropy 9.32 (sensitivity 88.9%, spe-
cificity 75.0%).
Discussion
The present study investigated the diffusion and perfusion
characteristics of pediatric abdominal tumors based on ADC
and IVIM models. We have demonstrated ADC and IVIM-
derived histogram parameters to be helpful in discriminating
between malignant neuroblastoma and Wilms’ tumors as
well as differentiating benign from malignant lesions. Dis-
tinctive IVIM-derived D* and f histogram parameters were
revealed for Wilms’ tumors and neuroblastomas. No signifi-
cant differences were observed with D or ADC histogram
parameters for the individual tumor types. Discrimination
of benign from malignant lesions was possible with the dif-
fusion coefficients ADC, D, and D*, but not with f histo-
gram parameters. These results suggest that the complex,
heterogeneous structures of abdominal tumors can be char-
acterized using histogram analysis, to potentially facilitate
their noninvasive diagnosis.
The use of an IVIM model or IVIM histogram analy-
sis for pediatric abdominal tumors has not been reported
previously. The histogram approach has been increasingly
used for heterogeneous tissues, allowing interpretation of the
complex nature and features seen in tumors.17 Previous
studies in adults have utilized histogram analysis of ADC
and cerebral blood volume (CBV), which has been applied
to a variety of scenarios including differentiation of true
tumor progression from pseudoprogression,28,29 response to
chemotherapy,30 and grading of tumors.31–33 Most previous
pediatric studies have reported mean or median ADC values
based on a single section or slice, which does not address
the heterogeneity seen in many abdominal tumors.7,8
Our results indicate that IVIM-derived histogram
parameters may facilitate discrimination between malignant
neuroblastoma and Wilms’ tumors. Comparison of Wilms’
tumors and neuroblastoma indicated significant differences
in the tumor perfusion characteristics. The perfusion influ-
enced parameters D* and f were found to be significant pre-
dictors of tumor type, while both ADC and D parameters
were unable to discriminate between them. Although these
tumors generally display different characteristic features,
both in terms of clinical presentation34 and on conventional
imaging,35,36 differentiating Wilms’ from neuroblastoma
FIGURE 3: Average perfusion fraction, f, histograms. Histograms shown for (a) hepatoblastoma (n54), neuroblastoma (n511),
and Wilms’ tumor (n58). The (b–d) histograms indicate the SD (shown in gray) between cases in each major tumor group.
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may cause diagnostic confusion in the case of intrarenal
neuroblastoma,37,38 or if the tumor involves the adrenal
gland.39 Neuroblastomas commonly encase vascular struc-
tures,34 which could be observed as an increase in D* and f
parameters. The lack of correlation between IVIM and
ADC parameters in regions where f was 20–40% suggests
that higher f and D* values resulted from pathology rather
than image artifact. This finding is of clinical importance,
as it could potentially be applied to other tumors, which are
more difficult to discriminate clinically, such as
distinguishing Wilms’ from renal rhabdoid or clear-cell sar-
coma of the kidney, or mesoblastic nephroma. This is par-
ticularly relevant given the recommendation to avoid
pretreatment biopsy in these tumors.40
In addition to the higher values of the IVIM perfusion
parameters, higher skewness for D* and higher entropy for f
were observed in neuroblastoma. This is suggestive of a
more irregular and heterogeneous vasculature of neuroblas-
toma compared to Wilms’ tumors. Diagnostic performance
with sensitivity and specificity above 85% was achieved with
FIGURE 4: Histologically verified low-risk Wilms’ tumor. (a) T2-weighted and (b) b5150 axial images, and (c–f) parametric maps
(ADC, D, D*, and f, respectively). Whole tumor ROI is shown drawn on the parametric maps. The calculated median values of
ADC, D, D*, and f for the drawn ROI were 768 3 1026 mm2/s, 677 3 1026 mm2/s 13,726 3 1026 mm2/s, and 10%, respectively.
FIGURE 5: Histologically verified neuroblastoma (grade IV). (a) T2-weighted and (b) b5150 images, and (c–f) parametric maps
(ADC, D, D*, and f, respectively). Whole tumor ROI is shown drawn on the parametric maps. The calculated median values of
ADC, D, D*, and f for the drawn ROI were 1155 3 1026 mm2/s, 703 3 1026 mm2/s, 17,762 3 1026 mm2/s, and 23%, respectively.
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D* mean, median, 75th/90th percentiles, and skewness, and
with f using mean, median, 75th/90th percentiles, kurtosis,
and entropy.
Cellularity and vascularity have been hypothesized to
increase in a similar manner, corresponding to a decrease in
ADC and increase in f. Interestingly, voxelwise correlations
in neuroblastoma and Wilms’ cases demonstrated this to be
true for D and f, with negative correlation shown, whereas
ADC and f showed positive correlation. This agrees with
the IVIM model and the proposed “true” tissue coefficient
D, and the contribution of both diffusion and vascular char-
acteristics to the measure of ADC.
A review of our results in a clinical context revealed
the interesting observations that tumors following an
unusual clinical course often had f values differing from
others in the same tumor group. Tumors behaving particu-
larly aggressively tended to have higher f values, whereas
those following a more indolent course had lower f values.
The mean f value for Wilms’ tumors in our cohort was
11.06 0.8%; the patient with the highest mean f value
(14.4%) died following a very aggressive disease process
with multiple relapses. Rhabdoid tumors are typically
aggressive malignancies with poor survival. The two patients
in our cohort with rhabdoid tumors had mean f values of
23.2% and 8.4%, the former died 3 months after presenta-
tion, whereas the latter remains in remission 2 years follow-
ing completion of treatment. This is suggestive of f being a
potential prognostic biomarker, with high-risk tumors hav-
ing high f values. This is biologically plausible, with
increased tumor vascularity reflected through an increase in
f. Although our numbers are too small to draw firm conclu-
sions, this interesting observation deserves further explora-
tion in a larger cohort.
Many of the benign lesion types included in this study
can be commonly diagnosed on conventional MRI. How-
ever, the benign cases in our cohort were a subset of these
that were suspected for malignancy and their diagnosis
based on clinical information and conventional MRI was
not possible. Therefore, all cases required histological verifi-
cation. Additional imaging methods such as DW-MRI can
FIGURE 6: ROC curves for diffusion parameters to compare the performance in discriminating benign from malignant tumors.
ROC curves for median (a) ADC, D, and D*, and the ROC curves with the highest AUC values for each parameter: (b) ADC skew-
ness, (c) D skewness, and (d) D* entropy.
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provide particularly useful information for diagnostically dif-
ficult cases. In our cohort, the discrimination of benign
from malignant lesions was feasible with the histogram
parameters of ADC, D, and D*. Of these parameters, the
best performance was observed with the ADC, which per-
formed well across the percentiles (75th percentile). It is
possible that ADC, influenced by both D and D*, has a
higher diagnostic performance due to the combinations of
diffusion and perfusion characteristics into a single parame-
ter. Interestingly, ADC and D were lower in malignant
tumors, while D* was higher. Quantitative assessment of
ADC is simpler than performing IVIM, and would be feasi-
ble to incorporate into clinical practice, with considerable
potential to improve patient care. The robust performance
of ADC across the percentiles also suggests that the use of
histogram analysis might be less relevant, and the use of
mean or median might be sufficient for discrimination of
benign from malignant lesions. This finding should be
tested with a cohort including a larger number of benign
cases.
The f parameter failed to reach significance in discrim-
ination of benign from malignant tumors. A wide range of f
values was observed for the benign cohort. This may reflect
differences in vasculature rather than cellularity, particularly
as benign lesions evaluated included a hemangioma and vas-
cular malformation. Although the f parameter may not
determine benign from malignant cases, it may be useful in
evaluating the vascular environment within lesions.
Our study has several limitations. First, the sample size
was relatively small for the comparison of individual tumor
types. However, the preliminary results are promising and
suggested discrimination may be possible, although further
validation is required in a larger cohort. Second, no T2 cor-
rection41 was applied to the perfusion fraction, and there-
fore the values could have been affected by the T2
relaxation times of blood and tissue. Third, the group sizes
were unbalanced for discrimination of benign from malig-
nant tumor types and further larger and multicenter studies
are required to confirm these results. Finally, while the
IVIM model is becoming more popular in abdominal appli-
cations, the biophysical origins of the IVIM parameters
require further exploration and justification. Promising
results were shown in a previous study of the pancreas,
which was able to verify the vascular contribution to the dif-
fusion signal by varying the echo time of the MR
acquisition.41
In conclusion, our results suggest that IVIM parame-
ters and their histogram analysis can provide useful insight
into the complex structures of pediatric abdominal tumors.
The use of multi b-value DW-MRI allowed the computa-
tion of IVIM parameters, and the whole-tumor ROI
approach ensured that the heterogeneity of the tumors was
taken into consideration. Our initial results in the childhood
abdominal tumors suggest that the use of IVIM perfusion
parameters, and in particular the perfusion fraction, could
facilitate the diagnosis of individual tumor types, and there-
fore provide a set of noninvasive imaging biomarkers for
their characterization.
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